Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Newman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Heart Journal|September 1, 1987
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patientsM M Applefeld, K A Newman, F J Sutton, et al.
The American Journal of Medicine|May 30, 1986
Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patientsC A De Jongh, J H Joshi, K A Newman, et al.
The American Journal of Cardiology|February 1, 1983
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failureM M Applefeld, K A Newman, W R Grove, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1993
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patientsJ H Joshi, K A Newman, B W Brown, et al.
Clinical Pharmacy|March 1, 1985
Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failureD S Roffman, M M Applefeld, W R Grove, et al.
Archives of Internal Medicine|October 1, 1986
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancerJ H Tenney, M R Moody, K A Newman, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
JAMA|July 10, 1981
Two methods for improved venous access in acute leukemia patientsJ C Wade, K A Newman, S C Schimpff, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsR S Finley, C L Fortner, C A deJongh, et al.
Cancer|July 15, 1986
Aspergillus sinusitis in cancer patientsA F Viollier, D E Peterson, C A De Jongh, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Heart Journal|September 1, 1987
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patientsM M Applefeld, K A Newman, F J Sutton, et al.
The American Journal of Medicine|May 30, 1986
Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patientsC A De Jongh, J H Joshi, K A Newman, et al.
The American Journal of Cardiology|February 1, 1983
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failureM M Applefeld, K A Newman, W R Grove, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1993
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patientsJ H Joshi, K A Newman, B W Brown, et al.
Clinical Pharmacy|March 1, 1985
Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failureD S Roffman, M M Applefeld, W R Grove, et al.
Archives of Internal Medicine|October 1, 1986
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancerJ H Tenney, M R Moody, K A Newman, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
JAMA|July 10, 1981
Two methods for improved venous access in acute leukemia patientsJ C Wade, K A Newman, S C Schimpff, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsR S Finley, C L Fortner, C A deJongh, et al.
Cancer|July 15, 1986
Aspergillus sinusitis in cancer patientsA F Viollier, D E Peterson, C A De Jongh, et al.
Pageof 4